A diet high in fiber and yogurt is associated with a reduced risk for lung cancer, according to a study by Vanderbilt University Medical Center researchers published in JAMA Oncology.
Oct 25, 2019
1
352
Men with breast cancer are more likely to die than their female counterparts, across all stages of disease, with the disparity persisting even when clinical characteristics, such as cancer types, treatment and access to care ...
Oct 22, 2019
0
8
(HealthDay)—Unselected, multigene testing for all patients with breast cancer would be cost-effective in the United Kingdom and the United States, according to a study published online Oct. 3 in JAMA Oncology.
Oct 10, 2019
0
2
A new analysis from TAILORx, the largest ever breast cancer treatment trial, is published today in JAMA Oncology. It reveals the clinical outcomes with chemotherapy in a subset of 1,389 women with a high Recurrence Score ...
Sep 30, 2019
0
3
(HealthDay)—Male breast cancer patients have higher mortality after cancer diagnosis than female patients, according to a study published online Sept. 19 in JAMA Oncology.
Sep 23, 2019
0
3
In what is believed to be the largest dataset study to date examining the role of race on survival outcome for pediatric patients with Hodgkin lymphoma, investigators at Rutgers Cancer Institute of New Jersey have found that ...
Sep 20, 2019
0
8
Early palliative care is associated with better survival in patients with advanced lung cancer, according to a study by VA Portland Health Care System and Oregon Health and Science University researchers.
Sep 19, 2019
0
2
Cancer patients on immunotherapy fare worse if they have recently taken antibiotics, with their response and overall survival rate "crashing."
Sep 13, 2019
0
463
Genetic testing for all metastatic breast cancer patients may be an optimal strategy for identifying additional patients with increased risk as well as response to targeted therapies, according to research published in JAMA ...
Sep 9, 2019
0
2
New research published this week in JAMA Oncology has found a lack of racial and ethnic diversity in clinical trials for cancer drugs.
Aug 15, 2019
0
2
